No Data
No Data
SoftBank's 24/3 operating profit down 17.4% to 876 billion yen, 25/3 forecast 2.7% increase to 900 billion yen
The financial results for the fiscal year ending 2024/3 announced by SoftBank <9434> were sales of 6.84 billion yen, up 2.9% from the previous fiscal year, and operating profit of 876 billion 68 billion yen, down 17.4% from the same period. As for the financial results for the fiscal year ending 2025/3, we plan that sales will increase 1.9% from the previous fiscal year to 6.2 trillion yen, and operating profit will increase 2.7% to 900 billion yen. Consumer businesses, etc., including the main mobile, are expected to grow. Sales of terminals will increase, and profit will increase as sales fees decrease.
Noevir Holdings 1H Net Y2.60B Vs Net Y2.67B
Noevir Holdings Co. Ltd. (4928.TO) Japan 1st Half Ended March 31 GROUP 2024 2023 Revenue Y31.63 bln Y30.90 bln Operating Profit Y6.17 bln Y5.7
Express News | Noevir Holdings 6-Mth Group Recurring Profit 6.25 Bln Yen (+7.5 %), 2023/24 Forecast Profit 11.40 Bln Yen (+0.9 %)
Noevir Holdings: Consolidated Financial Results for the 2nd Quarter Ending 2024/9 [Japanese GAAP] (Consolidated)
Kirin HD, Takeda Pharmaceutical, Sumitomo, SoftBank (9th)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/9 (Thu) <1375>Snow Country Maitake <1720>Tokyu Construction<1738>Nittoh <1764>Kudo Construction<1788>Santo Kogyo <1799>Daiichi Kenset<1869>Meikouken <1870>Yahagi Kenset<1929
List of Yunlou stocks [Ichimoku equilibrium table/ Yunlou stock list]
○Kumojo Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime <1814> Daisue Ken 1631 1624.5 1526 <2784> Alfresa 2390 2252.25 2354.5 <3593> HogiMedi 3780 3760 3620 <4668> Meiko Net
No Data